01 1Curia
01 1REGADENOSON
01 1U.S.A
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2018-05-24
Pay. Date : 2016-09-20
DMF Number : 30542
Submission : 2016-05-10
Status : Active
Type : II
20
Curia Missouri Inc, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
They are recognized for Curia- A partner for the pharma and biotech industries to improve patient outcomes & quality of life.
One of their notable products is REGADENOSON, with a corresponding US DMF Number 30542.
Remarkably, this DMF maintains an Active status since its submission on May 10, 2016, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of May 24, 2018, and payment made on September 20, 2016, indicating their dedication to facilitating drug approvals, Categorized as Type II
